Atlas Trials

Pharmacokinetics (PK) of 20 mg Teduglutide in Participants With Moderately Impaired Hepatic Function Compared to Healthy Participants

Clinical trial NCT00819468 · COMPLETED

Trial details

NCT number
NCT00819468
Sponsor
Shire
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2007-07-26
Primary completion
2007-08-23
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.